QR Kod

Phase II study in children and adults under 40 years with newly diagnosed Langerhans cell histiocytosis: protocol for an LCH-19-MSMFB clinical trial in Japan

Introduction Although the prognosis of Langerhans cell histiocytosis (LCH) is excellent, the high recurrence rate and permanent consequences, such as central diabetes insipidus and LCH-associated neurodegenerative diseases, remain to be resolved. Based on previous reports that patients with high-ris...

Ful tanımlama

Kaydedildi:
Asıl Yazarlar: Akiko M Saito, Hiroya Hashimoto, Takehiko Doi, Arinobu Tojo, Hirokazu Kanegane, Hisanori Fujino, Aki Sato, Keizo Horibe, Yuta Kawahara, Yozo Nakazawa, Atsuko Nakazawa, Rintaro Ono, Kenichi Sakamoto, Ko Kudo, Kazuko Kudo, Ryu Yanagisawa, Toyotaka Kawamata, Osamu Miyazaki, Yasunori Ota, Atsushi Manabe, Kensuke Usuki, Hitoshi Kiyoi, Akira Morimoto, Yoko Shioda
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2024-06-01
Seri Bilgileri:BMJ Open
Online Erişim:https://bmjopen.bmj.com/content/14/6/e084159.full
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller